1 / 50

PATHOLOGY OF SMALL & LARGE INTESTINE DIVERTICULAR DISEASE

PATHOLOGY OF SMALL & LARGE INTESTINE DIVERTICULAR DISEASE. Diverticulum= blind pouch leading off the alimentary tract, lined by mucosa, communicating with gut lumen Acquired >> congenital (e.g. Meckel ’ s) May arise anywhere in GIT; colon is the most common site Two main factors:

krysta
Télécharger la présentation

PATHOLOGY OF SMALL & LARGE INTESTINE DIVERTICULAR DISEASE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PATHOLOGY OF SMALL & LARGE INTESTINEDIVERTICULAR DISEASE • Diverticulum= blind pouch leading off the alimentary tract, lined by mucosa, communicating with gut lumen • Acquired >> congenital (e.g. Meckel’s) • May arise anywhere in GIT; colon is the most common site • Two main factors: • 1) Weakness in the wall: defects at site of bv entry; congenital weakness (e.g. Marfan’s syndrome) • 2) Increased peristalsis and intra-luminal pressure: hard stools due to low-fiber diet results in exaggerated peristaltic contractions

  2. PATHOLOGY OF COLONIC DIVERTICULOSIS • Colonic diverticulosis is common in the West (50% of adults >60 yrs); associated with low-fiber diet • Multiple small 0.5-1 cm • Sigmoid colon is involved in 95% of patients • Gross examination: Prominent taeniae coli & circular muscle bundles due to muscular hypertrophy; outpouching may be visible from serosal surface • Histology: sacs with thin wall made of mucosa & submucosa surrounded by fat or intact peritoneum

  3. CLINICAL FEATURES OFCOLONIC DIVERTICULOSIS • Usually asymptomatic • Intermittent cramping or continuous LLQ discomfort, sensation of incomplete emptying of rectum • Complications: • Diverticulitis: accentuates symptoms, tenderness, fever • Peridiverticulitis, perforation, abscess or fistula • Fistula formation • Bleeding • Rx: High-fiber diet; surgery

  4. PATHOLOGY OF SMALL & LARGE INTESTINEBOWEL OBSTRUCTION • May occur at any level, but is more frequent in small intestine • May be acute or chronic • Clinical features: abdominal distension (+/- pain) , followed by vomiting, then constipation • May present at birth, during infancy, childhood or adulthood • Obstruction may be in the lumen, wall or extramural • Tumors and infarction account for 10-15% of small bowel obstruction • Hernias, intestinal adhesions, intussusception, and volvulus account for 80% of cases

  5. CLASSIFICATION OFBOWEL OBSTRUCTION • Mechanical: • Congenital: strictures, atresias, bands, imperforate anus, meconium in cystic fibrosis • Infants: hernias, intussusception • Adults: hernias, adhesions, tumors, inflammatory strictures, obstructive gallstones, fecaliths, foreign bodies, volvulus • Functional: • Paralytic ileus: electrolyte imbalance, neural injury, or reflex atony secondary to peritonitis • bowel infarction, • myopathies & neuropathathies (e.g. Hirschsprung’s)

  6. BOWEL OBSTRUCTIONHERNIAS • Weakness or defect in wall of peritoneal cavity with protrusion of a serosa-lined sac of peritoneum • Inguinal & femoral canals, umbilicus & surgical scars • Segments of viscera may protrude & become entrapped, mostly in inguinal hernias • If small bowel is involved, partial or complete obstruction of its lumen may follow • Incarceration: permenant trapping of hernial sac contents due to venous stasis & edema • Strangulation: Venous & arterial supply to entrapped viscus is compromised leading to infarction or gangrene

  7. BOWEL OBSTRUCTIONINTESTINAL ADHESIONS • Due to localized or generalized peritonitis secondary to: • Surgical procedures • Infection • Endometriosis • Rarely due to congenital fibrous bands • May result in intestinal obstruction, incarceration and strangulation • Fibrous bridges which develop between bowel segments creating closed loops through which viscera may slide & become entrapped (internal hernias)

  8. BOWEL OBSTRUCTIONINTUSSESCEPTION • Uncommon disorder where a segment of small intestine, constricted by a a wave of peristalsis, suddenly becomes telescoped into the immediately distal segment of bowel • Intussusceptum: trapped bowel segment • Intussuscipiens: bowel segment which envelops it • Mostly in infants & children of unknown pathogenesis • In adults, an intraluminal tumor may act as point of traction, pulling along a segment of bowel • Intestinal obstruction • Intestinal infarction due to trapping of mesenteric blood vessels

  9. INTUSSESCEPTION

  10. BOWEL OBSTRUCTIONVOLVULUS • Complete twisting of a loop of bowel about its mesenteric base of attachment • Mostly in small intestine; large intestine especially sigmoid & cecum, and other structures (e.g. ovary) may be involved • Constriction of venous outflow &/or arterial supply • Intestinal obstruction and infarction • Uncommon disorder, occuring in all ages when an intestinal segment becomes longer & the mesentary narrower • May be caused by colon malrotation & peritoneal bands

  11. SMALL & LARGE INTESTINETUMORS • Colonic tumors are much more common than small intestinal tumors • May arise from any layer of GIT wall (mucosa, submucosa, muscularis or serosa); most are of epithelial origin • The majority are benign; however, colonic cancers are a major cause of morbidity & mortality • Clinical presentation: • Asymptomatic; incidental finding • Blood per rectum; anemia • Bowel obstruction

  12. INTESTINALTUMORS • Benign: • Stromal tumors • Hyperplastic & adenomatous polyps • Lipomas • Malignant: • Adenocarcinoma • Carcinoid tumors • Lymphoma • Sarcoma

  13. PATHOLOGY OF SMALL & LARGE INTESTINECARCINOID TUMORS • Tumors of neuroendocrine cells, which are widely distributed cells of epithelial stem cell origin capable of producing a variety of bioactive compounds • Tumors may produce multiple compounds or a predominant product, causing a clinical syndrome such as gastrinoma, insulinoma ... • Tumors arrise in GIT, lung, biliary tree & pancreas • 50% of small intestinal & 2% of colonic tumors • Any age, peak incidence in 6th decade • Carcinoids are well differentiated tumors that are potentially malignant tumors and may metastasize

  14. CLINICAL FEATURES OFCARCINOID TUMORS • Sites: appendix>small intestine (ileum)>rectum> stomach>colon • Most are asymptomatic (particularly appendix) • May cause local symptoms (angulation or obstrcution of small intestine) • Secretory products may produce a variety of endocrinopathies, e.g. Zollinger-Ellison syndrome, Cushing’s syndrome, hyperinsulinism • Carcinoid syndrome: 1% of patients & 20% of those with widespread metastasis; due to serotonin secretion; vasomotor disturbances, intestinal hypermotility, hepatomegaly and systemic fibrosis

  15. PATHOLOGY OF CARCINOID TUMORS • Gross: usually small tumors, rarely >3 cm, forming an intramural or submucosal yellow-tan firm elevation or polypoid lesion • Histology: monomorphous population of cells with scant granular cytoplasm & round nuclei. Neoplastic cells form islands, nests, strands or glands. Intact or ulcerated overlying mucosa. • May be multicentric (stomach, ileum) • May be localized or have local spread &/or metastasis to lymph nodes or more distant sites, particularly liver

  16. CLINICAL BEHAVIOUR OFCARCINOID TUMORS • Clinical behaviour is difficult to predict from histologic features • Behaviour but generally depends on: • 1) Size: >2 cm and those invading >1/2 wall thickness • 2) Site: appendiceal & rectal carcinoids almost never metastasize • 5 years survival rate is excellent: 90% • 5 years survival rate for small intestinal tumors with liver metastasis: 50% • Widespread disease usually causes death

  17. SMALL INTESTINALADENOCARCINOMA • Most arise in duodenum, including ampulla of Vater • Polypoid fungating tumor growing in a napkin-ring encircling pattern • Early on, tumor is asymptomatic • Signs & symptoms usually appear late, when tumor has already penetrated bowel wall into mesentery, other bowel segments or spread to LN, or metastasize to liver or more widely • c/o symptoms of abdominal obstruction (pain, nausea, vomiting, and weight loss) • 5 yrs survival with wide en bloc excision: 70%

  18. SMALL & LARGE INTESTINEPOLYPS • Polyp= a tumorous mass protruding into the lumen of the gut; may be pedunculated or sessile • Major types: • Non-neoplastic polyps: about 90% of polyps; formed as a result of abnormal mucosal maturation, inflammation or architecture • Hyperplastic polyps • Hamartomatous polyps • Inflammatory polyps • Neoplastic polyps: formed as a result of epithelial proliferation and dysplasia, i.e. pre-cancerous • Adenomatous polyps

  19. INTESTINAL POLYPSHYPERPLASTIC POLYPS • Majority of polyps • Site: mostly in colon, >50% in rectosigmoid • Patients: increase in frequency with age • Appearance: Most are small <5 mm, nipple-like protrusion; multiple or single • Pathology: histologically consist of abundant crypts lined by well-differentiated goblet or absorptive epithelial cells, seperated by scant lamina propria • Asymptomatic or blood &/or mucus per rectum • No malignant potential

  20. INTESTINAL POLYPSHAMA‏RTOMATOUS POLYPS • Juvenile polyps: • Hamartomatous proliferation of lamina propria surrounding cystically dilated glands • Patients: usually <5 yrs; in adults called “retention polyp” • Appearance:1-3 cm in children; smaller in adults • Single rounded or lobulated, +/- stalk • Bleeding per rectum; stalk may twist and undergo painful infarction • No malignant potential

  21. INTESTINAL POLYPSHAMA‏RTOMATOUS POLYPS • Peutz-Jeghers polyps: • Rare autosomal dominant syndrome, characterized by GIT polyps, melanotic mucosal and cutaneous pigmentation around lips, oral mucosa, face, genitalia & palmar surfaces of hands • Site: polyps may occur in stomach (25%), colon (30%) and small intestine (100%) • Appearance: large peduculated lobulated polyps • Pathology: branching framework of connective tissue & smooth muscle • Polyps have no malignant potential, but PJS patients have increased risk of developing carcinoma of pancreas, breast, lung, ovary & uterus

  22. INTESTINAL POLYPSA‏DENOMATOUS POLYPS • Vast majority of adenomas arise in colon • Variable in size; pedunculated or sessile • Results from epithelial proliferation and dysplasia, which may range from mild to carcinoma in situ • Three architectural types: • 1) Tubular adenoma • 2) Villous adenoma • 3) Tubulovillous adenoma • Risk of malignant transformation depends on: • Polyp size: <1 cm (v. rare); 1-2 cm (10%); >2 cm (45%) • Histologic architecture: proportion of villous component • Severity of dysplasia

  23. INTESTINAL POLYPSA‏DENOMATOUS POLYPS • Tubulovillous adenoma: 5-10% of adenomatous polyps; mixture of tubular & villous (20-50%) areas; intermediate in frequency of having a stalk, size, degree of dysplasia & risk of carcinoma • Clinical features: 20-30% are <40 yrs; 50% after 60 • Small polyps: asymptomatic • Occult bleeding, anemia, hypoproteinemia & hypokalemia • Intestinal obstruction or biliary obstruction • Rx: Most are cured by adequate endoscopic excision • Px:Annual endoscopic follow-up

  24. >85% of adenomas Majority in distal colon; 50% in rectosigmoid Most are small (few mm-2 cm) with a stalk (-2 cm) Histology shows neoplastic epithelium forming glands & tubules Variable degrees of dysplasia to CIS Invasive carcinoma rare 1% of adenomas Rectum & rectosigmoid 75%, followed by cecum & ascending colon Sessile ranging from 1-10 cm (most are 1-3 cm) Histology shows neoplastic cells forming villi (>50% villous) Carcinoma in situ 10% Invasive carcinoma 30% ADENOMATOUS POLYPSTUBULAR ADENOMA VILLOUS ADENOMA

  25. INTESTINAL POLYPSFAMILIAL POLYPOSIS SYNDROMES • Familial adenomatous polyposis (FAP): • Rare autosomal dominant trait • Dx: at least 100 polyps (average 1000) • Most are tubular adenomatous polyps • Genetic defect of APC gene localized to chromosome 5q21 • Risk of colon cancer: 100% at 30 years • Rx: Prophylactic colectomy • Gardner’s syndrome: • + osteomas, epidermal cysts, fibromatosis, thyroid Ca.. • Turcot’s syndrome: • + CNS tumors (gliomas)

  26. INTESTINAL POLYPSFAMILIAL POLYPOSIS SYNDROMES • Lynch’s syndrome: • aka: Hereditary nopolyposis colorectal cancer (HNPCC) • Autosomal dominant syndrome characterized by an increased risk of colorectal cancer and extra-intestinal cancer, particularly endometrial carcinoma • Multiple recurrent colorectal adenomatous polyps which present ar an early age • Mutations in any of 4 genes (MSH2, MLH1, PMS1 & PMS2) involved in DNA repair, located in chromo-somes 2, 3 & 7, resulting in microsatellite instability • Colonic carcinoma is typically located proximal to splenic flexure, often multiple, and not arising in preexisting adenomas

  27. TUMORS OF LARGE INTESTINECOLORE‏CTAL ADENOCARCINOMA • More than 98% of colonic malignancies • Second most common cancer • Peak incidence 60-70 yrs; <20% before age of 50 yrs • Wide geographic variation in incidence; more frequent in Western industrialized nations • Environmental dietary factors have been implicated: • Low unabsorbable vegetable fiber content • High refined crabohydrate content • High fat content • Low protective micronutrients content (vit. A, C & E) • Almost always arise in adenomatous polyps

  28. COLORECTAL ADENOCARCINOMATHE ADENOMA-CARCINOMA SEQUENCE • Cumulative alterations in the genome lead to progressive increase size, dysplasia & invasive potential • “Multi-hit” concept for colon cancer carcniognesis: • First hit: germline or somatic mutations of cancer suppressor genes i.e. APC & mismatch repair genes • Second hit: Methylation abnormalities & inactivation of of normal alleles of APC & mismatch repair genes • Protooncogene mutation, e.g. K-ras at 12p12 • Homozygous loss of addtional cancer suppressor genes, e.g. DCC at 18q21 and p53 at 17p13 • Additional mutations of many genes will occur in carcinoma

  29. PATHOLOGY & CLINICAL FEATURES OFCOLORECTAL ADENOCARCINOMA • Majority are sporadic; 1-3% in patients with FAP or IBD • Mostly single; location is shifting to the right colon • Proximal colon: fungating polypoid tumors • Distal colon: annular encircling tumors (napkin-ring) • Tumors penetrate colonic wall layer into serosal surface • Histology range from well differentiated to undifferentiated; may be mucin-secreting • Asymptomatic for year • Right: fatigue, weakness, iron-deficiency anemia • Left: occult bleeding, change in bowel habit, discomfort • Dx: PE, lab, X-ray, endoscopy and biopsy

  30. COLORECTAL ADENOCARCINOMAModified Dukes’ (Astler-Coller) Staging System

  31. TUMORS OF SMALL & LARGE INTESTINEINTESTINAL LYMPHOMA • The GIT is the most common extranodal location of lymphomas • May be primary or secondary • Primary GI lymphoma: no evidence of liver, spleen or bone marrow involvement at diagnosis • Adults, M=F, stomach>small intestine>colon • Classification similar to nodal lymphomas: MALTomas, large cell lymphoma, … etc. • Nonspecific symptoms • Rx: surgery, chemo- and radiotherapy • Px: better than nodal lymphomas

More Related